Gallbladder cancer natural history: Difference between revisions
Varun Kumar (talk | contribs) |
Varun Kumar (talk | contribs) |
||
| Line 6: | Line 6: | ||
==Disease Course== | ==Disease Course== | ||
Most tumors are [[adenocarcinoma]]s, with a small percent being [[squamous cell]] carcinomas. The cancer commonly spreads to the [[liver]], [[pancreas]], [[stomach]],and [[duodenum]]. | Most tumors are [[adenocarcinoma]]s, with a small percent being [[squamous cell]] carcinomas. The cancer commonly spreads to the [[liver]], [[pancreas]], [[stomach]],and [[duodenum]]. | ||
==Prognosis== | |||
The prognosis for any treated cancer patient with progressing or recurrent gallbladder cancer is poor. The question and selection of further treatment depends on many factors: tumor burden, prior treatment, site of recurrence, and individual patient considerations. Patients may have portal hypertension caused by portal vein compression by the tumor. Transperitoneal and intrahepatic metastases are not uncommon. Clinical trials are appropriate and should be considered when possible. | |||
==References== | ==References== | ||
Revision as of 02:28, 22 January 2012
|
Gallbladder cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gallbladder cancer natural history On the Web |
|
American Roentgen Ray Society Images of Gallbladder cancer natural history |
|
Risk calculators and risk factors for Gallbladder cancer natural history |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Disease Course
Most tumors are adenocarcinomas, with a small percent being squamous cell carcinomas. The cancer commonly spreads to the liver, pancreas, stomach,and duodenum.
Prognosis
The prognosis for any treated cancer patient with progressing or recurrent gallbladder cancer is poor. The question and selection of further treatment depends on many factors: tumor burden, prior treatment, site of recurrence, and individual patient considerations. Patients may have portal hypertension caused by portal vein compression by the tumor. Transperitoneal and intrahepatic metastases are not uncommon. Clinical trials are appropriate and should be considered when possible.
References